Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that several MORU Network colleagues were honoured in the recent University of Oxford Recognition of Distinction rounds. Clockwise from top left: Joel Tarning was awarded the title of Professor of Clinical Pharmacology and Lisa White Professor of Modelling and Epidemiology. Stuart Blacksell, Susanna Dunachie, Paul Turner, Richard Maude, Frank Smithuis and Phaik Yeong Cheah were each awarded the title of Associate Professor.

Joel Tarning, Lisa White, Stuart Blacksell, Susie Dunachie, Phaik Yeong Cheah, Frank Smithuis, Richard Maude and Paul Turner

We are delighted to announce that several MORU Network colleagues were honoured in the recent University of Oxford Recognition of Distinction rounds. Clockwise from top leftJoel Tarning was awarded the title of Professor of Clinical Pharmacology and Lisa White Professor of Modelling and Epidemiology. Stuart BlacksellSusanna DunachiePaul TurnerRichard MaudeFrank Smithuis and Phaik Yeong Cheah were each awarded the title of Associate Professor.

In addition, two colleagues at LOMWRU, MORU’s Lao PDR unit, received significant recognition for their work: David Dance, LOMWRU’s Clinical Research Microbiologist and Unit Safety Officer, was made Honorary Professor at the London School of Hygiene and Tropical Medicine (LSHTM), and Dr Minivan Vongsouvath, Deputy Director of LOMWRU’s Microbiology Lab and Deputy Head of Virology, was recently awarded her MSc in Clinical Tropical Medicine from Mahidol University.

Similar stories

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

COPCOV investigators meet, and prepare to submit for publication

On 15-16 Dec, COPCOV investigators from around the world met in Bangkok to review study results and plan next steps. Led by co-PIs Prof Sir Nick White and Dr Will Schilling, and funded by the Wellcome Trust, the MORU-led COPCOV ( Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting) is the world’s largest multinational trial of COVID-19 prevention.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Are we getting tafenoquine dosing right?

Researchers analysing clinical trial data for the new antimalarial drug tafenoquine find that higher doses are needed to cure reliably vivax malaria infection.

New SMRU building opened in Thailand to provide health care to marginalized populations

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.